Cann10, a medical cannabis company, has partnered with biotech company Epigenetics on a quest to create a new breed of “mega-cannabis” that is easier to cultivate and produces higher yields.
Zoë Biehl is a professional writer and editor in the cannabis and technology spaces. She also is founder of Wild Lotus, a boutique digital content agency that provides high-quality content to publications and businesses around the world.
The two Israeli companies have formed a joint company named Cann10 EpiGen that has begun research on utilizing an epigenetics breeding technology on cannabis plants.
WHAT IS EPIGENETICS?
In literal terms, epigenetics is defined as “on top of” or “above” genetics. Using the practice of epigenetics, researchers learned to make external modifications to DNA in order to switch genes either “on” or “off,” similar to how a computer uses binary code. The DNA sequence is not directly altered or modified, but the way the genes are interpreted by cells is changed.
HOW CANN10 EPIGEN USE ADVANCED TECHNIQUES FOR BETTER CANNABIS
In this case, the epigenetics technique involves using a breeding process that reveals hidden parts of the plant’s DNA and enables select genes to express themselves.
It’s important to note that this process is not the same as genetic modification, as some cannabis news outlets have mistakenly reported. Epigenetics does not actually change the DNA itself —
